About the journal
BMC Clinical Pharmacology is a journal published by BioMed Central in United Kingdom. It is listed in PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- BioMed Central
- ISSN
- 1472-6904
- Country
- United Kingdom
- Access
- Not open access / not declared
- Declared peer-review model
- peer_review
- Official website
- http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=21
Index listings
- PUBMED · 2002-02-27
- Indexing
- PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Dormant — no works recorded since 2012
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
134
Last recorded publication year
2012
h-index
51
i10-index
122
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2012
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 0%
- ORCID iDs in current deposits
- 0%
Identity & continuity2
- Alternate titles
- BioMed Central clinical pharmacologyClinical pharmacology
- Source type
- journal
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Pharmacogenetics and Drug Metabolism
- Pharmacovigilance and Adverse Drug Reactions
- Pharmacovigilance and Adverse Drug Reactions
- Pharmacovigilance and Adverse Drug Reactions
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical Practices and Patient Outcomes
- Medication Adherence and Compliance
- Medication Adherence and Compliance
Show all subjects (75)
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical studies and practices
- Antibiotics Pharmacokinetics and Efficacy
- Opioid Use Disorder Treatment
- Opioid Use Disorder Treatment
- Antibiotics Pharmacokinetics and Efficacy
- Pain Management and Opioid Use
- Patient Safety and Medication Errors
- Antibiotics Pharmacokinetics and Efficacy
- Pain Management and Opioid Use
- Pharmaceutical industry and healthcare
- Poisoning and overdose treatments
- Pain Management and Opioid Use
- Poisoning and overdose treatments
- Antibiotic Use and Resistance
- Pharmaceutical Economics and Policy
- Inflammatory mediators and NSAID effects
- Antibiotic Use and Resistance
- Biosimilars and Bioanalytical Methods
- Anesthesia and Pain Management
- Inflammatory mediators and NSAID effects
- Lipoproteins and Cardiovascular Health
- Complementary and Alternative Medicine Studies
- Drug-Induced Adverse Reactions
- Pharmacy and Medical Practices
- Drug-Induced Adverse Reactions
- Opioid Use Disorder Treatment
- Drug Transport and Resistance Mechanisms
- Blood Pressure and Hypertension Studies
- Alcoholism and Thiamine Deficiency
- Lipoproteins and Cardiovascular Health
- Drug Transport and Resistance Mechanisms
- Forensic Toxicology and Drug Analysis
- Pharmacogenetics and Drug Metabolism
- Pharmaceutical industry and healthcare
- Patient Safety and Medication Errors
- Analytical Methods in Pharmaceuticals
- Meta-analysis and systematic reviews
- Health Systems, Economic Evaluations, Quality of Life
- Poisoning and overdose treatments
- Alcoholism and Thiamine Deficiency
- Meta-analysis and systematic reviews
- Lipoproteins and Cardiovascular Health
- Blood Pressure and Hypertension Studies
- Medication Adherence and Compliance
- Pharmacogenetics and Drug Metabolism
- Forensic Toxicology and Drug Analysis
- Pharmaceutical industry and healthcare
- Patient Safety and Medication Errors
- Diabetes Treatment and Management
- Substance Abuse Treatment and Outcomes
- Sepsis Diagnosis and Treatment
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pharmaceutical Economics and Policy
- Anesthesia and Sedative Agents
- Neurotransmitter Receptor Influence on Behavior
- Drug-Induced Hepatotoxicity and Protection
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Drug-Induced Hepatotoxicity and Protection
- Drug Solubulity and Delivery Systems
- Neurotransmitter Receptor Influence on Behavior
- Substance Abuse Treatment and Outcomes
- Pharmaceutical Economics and Policy
- Substance Abuse Treatment and Outcomes
- Blood Pressure and Hypertension Studies
- Schizophrenia research and treatment
- Schizophrenia research and treatment
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ